Koichi Kitagawa 北川孝一

Researcher Number	00822884
Other IDs
Affiliation (based on the past Project Information) *help	2021 – 2023: 神戸大学, 科学技術イノベーション研究科, 特命助教 2019 – 2021: 神戸大学, 科学技術イノベーション研究科, 助教
Review Section/Research Field	Principal Investigator Basic Section 56030:Urology-related Except Principal Investigator Basic Section 56030:Urology-related / Basic Section 90150:Medical assistive technology-related / Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator 癌免疫療法 / 粘膜免疫 / 腫瘍関連抗原 / 膜輸送性ペプチド / 膀胱癌 / WT1 / 経口癌ワクチン / T細胞 / 免疫チェックポイント阻害薬 / 尿路上皮癌 / 免疫療法 / ビフィズス菌 / 腫瘍免疫 … More Except Principal Investigator … More 免疫チェックポイント阻害薬 / 経口がんワクチン / WT1 / 腎癌 / 経口ワクチン / がんワクチン / 免疫療法 / 物理療法 / がん細胞 / マクロファージ / 骨格筋エクソソーム / 前立腺癌 / 癌幹細胞 / 遺伝子治療 / 低酸素誘導因子 / CD44 / 癌遺伝子治療 / アデノウイルス Less

Exploration of the therapeutic potential of an oral WT1 vaccine in combination with immune checkpoint inhibitors for enhancing the anti-cancer effects in renal cancer
- Principal Investigator
  
  植木秀登
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kobe University
Development of a novel cancer gene therapy targeting prostate cancer stem cell
- Principal Investigator
  
  白川利朗
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Kobe University
Intranasal delivery of cancer vaccine combined with cell-penetrating peptide and longer tumor antigens for bladder cancerPrincipal Investigator
- Principal Investigator
  
  北川孝一
- Project Period (FY)
  2022 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kobe University
生体免疫を是正・補完する骨格筋複合物理刺激装置の開発
- Principal Investigator
  
  前重伯壮
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 90150:Medical assistive technology-related
- Research Institution
  Kobe University
Combination immunotherapy of oral vaccination with immune checkpoint inhibitor for bladder cancerPrincipal Investigator
- Principal Investigator
  
  Koichi Kitagawa
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kobe University

All 2023 2022 2021 2020 2019

All Journal Article Presentation Patent

[Journal Article] A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer2023
- Author(s)
  A Ruhan、Kunimura Naoto、Tominaga Shoko、Hirata Erika、Nishioka Shunya、Uesugi Misato、Yamazaki Rion、Ueki Hideto、Kitagawa Koichi、Fujisawa Masato、Shirakawa Toshiro
- Journal Title
  
  Frontiers in Oncology
  
  Volume: 13
- DOI
  10.3389/fonc.2023.1147668
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07252
[Journal Article] An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model2023
- Author(s)
  Ueki Hideto、Kitagawa Koichi、Kato Mako、Yanase Shihoko、Okamura Yasuyoshi、Bando Yukari、Hara Takuto、Terakawa Tomoaki、Furukawa Junya、Nakano Yuzo、Fujisawa Masato、Shirakawa Toshiro
- Journal Title
  
  Scientific Reports
  
  Volume: 13 Issue: 1 Pages: 9994-9994
- DOI
  10.1038/s41598-023-37234-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K08757
[Journal Article] An oral cancer vaccine using a Bifidobacterium vector suppresses tumor growth in a syngeneic mouse bladder cancer model2021
- Author(s)
  Kitagawa Koichi、Tatsumi Maho、Kato Mako、Komai Shota、Doi Hazuki、Hashii Yoshiko、Katayama Takane、Fujisawa Masato、Shirakawa Toshiro
- Journal Title
  
  Molecular Therapy - Oncolytics
  
  Volume: 22 Pages: 592-603
- DOI
  10.1016/j.omto.2021.08.009
- NAID
  120007162582
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K18559
[Patent] がんの遺伝子治療薬2023
- Inventor(s)
  白川利朗、北川孝一、アルハン
- Industrial Property Rights Holder
  国立大学法人神戸大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2023-196621
- Filing Date
  2023
- Data Source
  KAKENHI-PROJECT-22K07252
[Presentation] A recombinant adenovirus vector containing the synNotch receptor gene inhibits tumor growth of triple-negative breast cancer in a mouse xenograft model2023
- Author(s)
  Ruhan A, Koichi Kitagawa, Naoto Kunimura, Masato Fujisawa, Toshiro Shirakawa
- Organizer
  American Society of Gene & Cell Therapy (ASGCT)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K07252
[Presentation] synNotch技術を用いてCD44細胞外領域、Notch coreドメイン、HIF-3α4を連結させた融合遺伝子を含む組換えアデノウイルスベクターは膀胱癌マウスモデルにおいて腫瘍増殖を抑制した2023
- Author(s)
  アルハン、北川孝一、平田絵里佳、藤澤正人、白川利朗
- Organizer
  日本遺伝子細胞治療学会 (JSGCT)
- Data Source
  KAKENHI-PROJECT-22K07252
[Presentation] Intranasal Administration of Multi-Epitope Long Peptide with D-Octaarginine-Linked PNVA-co-AA as a Novel Drug Delivery System for Cancer Vaccine2022
- Author(s)
  Koichi Kitagawa, Maho Ishida, Akari Sasajima, Manami Kanda, Takumi Tomono, Shinji Sakuma, Toshiro Shirakawa
- Organizer
  SGCT 25th Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K09501
[Presentation] Preclinical Study of Oral Cancer Vaccine Using Recombinant Bifidobacterium Expressing WT1 Protein in Murine Bladder Cancer Model and Non-human Primate2020
- Author(s)
  Koichi Kitagawa, Mako Kato, Shota Komai, Ryota Sako, Hazuki Doi, Yoshiko Hashii, Takane Katayama,Toshiro Shirakawa
- Organizer
  American Society of Gene & Cell Therapy 23rd Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K18559
[Presentation] Oral cancer vaccine using recombinant Bifidobacterium expressing WT1 protein and anti-PD1 antibody induced WT1 specific immune responses via gut immune system in murine bladder cancer model2019
- Author(s)
  北川孝一, 國村尚人, 加藤真子, 駒井翔太, 土井葉月, 末田菜花, 橋井佳子, 片山高嶺, 白川利朗
- Organizer
  CRI-CIMT-EATI-AACR INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K18559
[Presentation] WT1 oral cancer vaccine combined with anti-PD-1 antibody completely suppressed tumor growth in a murine bladder cancer model2019
- Author(s)
  白川利朗, 北川孝一, 辰巳真帆, 門脇雅英, 片山高嶺, 橋井佳子, 藤澤正人
- Organizer
  CIMT 2019 Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K18559

1. 白川利朗 (70335446)

# of Collaborated Projects: 3 results

# of Collaborated Products: 5 results
2. 植木秀登 (00903296)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
3. 佐久間信至 (80388644)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
4. 前重伯壮 (90617838)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 西村勇哉 (40728218)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 金沢星慶 (60744993)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 重村克巳 (00457102)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Koichi Kitagawa 北川 孝一

Research Projects

Research Products

Co-Researchers

Exploration of the therapeutic potential of an oral WT1 vaccine in combination with immune checkpoint inhibitors for enhancing the anti-cancer effects in renal cancer

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a novel cancer gene therapy targeting prostate cancer stem cell

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Intranasal delivery of cancer vaccine combined with cell-penetrating peptide and longer tumor antigens for bladder cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

生体免疫を是正・補完する骨格筋複合物理刺激装置の開発

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Combination immunotherapy of oral vaccination with immune checkpoint inhibitor for bladder cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] An oral cancer vaccine using a Bifidobacterium vector suppresses tumor growth in a syngeneic mouse bladder cancer model2021

Author(s)

Journal Title

DOI

NAID

Data Source

[Patent] がんの遺伝子治療薬2023

Inventor(s)

Industrial Property Rights Holder

Industrial Property Rights Type

Industrial Property Number

Filing Date

Data Source

[Presentation] A&#160;recombinant adenovirus vector&#160;containing&#160;the&#160;synNotch&#160;receptor&#160;gene&#160;inhibits tumor growth of triple-negative breast cancer in a&#160;mouse&#160;xenograft model2023

Author(s)

Organizer

Data Source

[Presentation] synNotch技術を用いてCD44細胞外領域、Notch coreドメイン、HIF-3α4を連結させた融合遺伝子を含む組換えアデノウイルスベクターは膀胱癌マウスモデルにおいて腫瘍増殖を抑制した2023

Author(s)

Organizer

Data Source

[Presentation] Intranasal Administration of Multi-Epitope Long Peptide with D-Octaarginine-Linked PNVA-co-AA as a Novel Drug Delivery System for Cancer Vaccine2022

Author(s)

Organizer

Data Source

[Presentation] Preclinical Study of Oral Cancer Vaccine Using Recombinant Bifidobacterium Expressing WT1 Protein in Murine Bladder Cancer Model and Non-human Primate2020

Author(s)

Organizer

Data Source

[Presentation] Oral cancer vaccine using recombinant Bifidobacterium expressing WT1 protein and anti-PD1 antibody induced WT1 specific immune responses via gut immune system in murine bladder cancer model2019

Author(s)

Organizer

Data Source

[Presentation] WT1 oral cancer vaccine combined with anti-PD-1 antibody completely suppressed tumor growth in a murine bladder cancer model2019

Author(s)

Organizer

Koichi Kitagawa 北川孝一

[Presentation] A recombinant adenovirus vector containing the synNotch receptor gene inhibits tumor growth of triple-negative breast cancer in a mouse xenograft model2023